About B2S Life Sciences

We provide superior custom reagent products and services that are tailored to our clients’ needs and manage these products and services for clients throughout the drug development process with pre-analytical and post-analytical services.

Our combination of expertise, products, and services thereby uniquely qualifies us to better the development process for biotherapeutic drugs, CROs, pharma, biotech and diagnostics.

    Meet Our Team

    Executive Team

    Ronald R. Bowsher PH.D.

    Partner & Chief Scientific Officer

      Aleks Davis BS, MBA

      Partner & Chief Executive Officer 

        Technical Team

        Derrick Johnson, PhD

        Director of Assay Development

        Sanofar J. Abdeen PhD

        Associate Director – R&D Custom Reagents

        Swarna Ramaswamy PhD

        Lead Research Scientist

        Sherri Rinker, PhD

        Associate Director of Regulated Bioanalysis

        Rick Delhaye

        Principal Investigator (Team Lead)

        Nathan McOwen

        Scientist III

        Adam Kinne

        Senior Scientist, Custom Reagents

        Vish Chandrahas

        Sr. Scientist II

        Elizabeth Rempala

        Manager of Quality Operations

        Hannah Gill

        Operations Supervisor

        Jamie Colwell

        Logistics Sample Inventory Supervisor

        Business Team

        Melissa Johnson

        Director of Client Engagement and Marketing

         

          Julie Williams

          Project Coordinator

          Charla Smith

          Business Development Coordinator

          Lori Huddleston

          Business Operations Manager

          Amy Fisher SHRM-CP

          Human Resources Manager

          Who We Are

          B2S Life Sciences is not a typical CRO. Rather, we are a Biotherapeutic Enablement Company. We advance biotherapeutic drug development by providing optimized critical reagents for improved analytical methods and outcomes for companies involved in the development of biotherapeutic drugs and diagnostics. Additionally, we provide support for biotherapeutic drug development from late phase discovery through BLA submission. Our major focus is on the design, generation, purification and life cycle management of custom critical reagents to support Regulated Bioanalysis and CMC assays of biotherapeutics. Our custom reagents are specifically designed and manufactured to be optimal for the intended analytical purpose. Moreover, we store our custom critical reagents in our proprietary LCM+ inventory system to maintain these products in a controlled manner to help ensure long term stability, consistency in performance and provide a well-documented chain-of-custody for regulatory compliance. When combined with our range of downstream services novel business model and services uniquely qualifies us to meet the drug development needs for pharma, biotech, CROs and diagnostics.

           

          Our mission is to leverage our extensive expertise in bioanalytical methods, development and statistical analysis to:

              1. Help ensure technical success
              2. Create value
              3. Make a positive impact on discovery and development projects and regulatory submissions for our clients’ therapeutic products and devices.

           

          Our Core Mission

          B2S Life Science’s CORE MISSION is to design, generate, purify, characterize, and perform life cycle management of custom critical reagents, combined with complementary downstream activities, including:

          • Assay development and qualification
          • Non-GLP bioanalysis and CRO oversight for GLP bioanalysis
          • Data analytics services, including PK/TK, immunogenicity cut point statistics, clinical immunogenicity, and support for IND/NDA/BLA submissions

          B2S Life Sciences strives to maximize R&D quality and efficiency by enabling successful regulatory submissions of biotherapeutics.

          B2S Life Sciences Offers:

          • Pre-Analytical thru Post-Analytical services to extend the range of capabilities typically found at conventional bioanalytical CROs
          • Provide services for unmet drug development needs
          • Serve as a consultative advisory partner
          • Support both large & small molecule therapeutic

          Our History

          Incorporated in 2002 as Bowsher Brunelle Smith LLC (d/b/a B2S Consulting), we were founded as an Indianapolis-based firm offering a range of consulting services to support research and development of biotherapeutics and conventional pharmaceuticals.

          Leveraging decades of combined experience in drug development and applied statistics, Dr. Ronald Bowsher and his business partners offered cutting-edge and in-depth support for nonclinical and clinical drug development.

          In January 2017, our core competencies were consolidated under the network of B2S Life Sciences, a service-driven biotherapeutic enablement company offering premier laboratory analysis and life cycle management of custom reagents.

          Today, B2S Life Sciences serves pharma and biotechnology clients by offering a wide range of pre-analytical (generation of custom reagents) and post-analytical (data analytics and statistics, pharmacokinetic data analysis and clinical immunogenicity) services.

          Contact us

          We are here to help! Fill the contact form below to schedule a call with one of our scientists.

          B2S Website Form - Contact Us

          "*" indicates required fields

          Step 1 of 4

          Name*